Opportunities Preloader

Please Wait.....

Report

Microneedle Drug Delivery Systems Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

Market Report I 2023-01-23 I 120 Pages I Mordor Intelligence

The microneedle drug delivery systems market is projected to register a CAGR of 7.8% during the forecast period of 2022-2027.

The healthcare system has witnessed enormous challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to ?reduce the risk of viral transmission as most chronic pain therapies were regarded as non-urgent. On the other hand, COVID-19 provides ample growth opportunities to the studied market, which is likely to dramatically increase patient footfall post-pandemic. Since then, the demand for COVID-19 vaccines is anticipated to increase, and the market for microneedle drug delivery systems is estimated to expand more quickly as these systems are non-invasive and painless.

Microneedle patch immunization has been extensively studied for its non-invasive technique. The vaccine hesitancy has been listed as one of the top ten threats to global health by the World Health Organization. A survey by Lazarus JV et al., in October 2020 showed that around 53.1% of the studied people opted not to be vaccinated or were not sure whether they should be vaccinated. The vaccine hesitancy is usually a result of needle phobia and fear of pain and complications. The growing demand for needle-less and pain-less microneedle patches is expected to propel the growth of the market.

Injectables have been a concern because of their invasive nature, thermo-stability issues, and necessity for highly skilled practitioners. Needlestick injuries (NSIs) are a serious concern to healthcare professionals. According to the World Health Organization, healthcare workers encounter more than two million NSIs annually. The complications associated with the injectables paved the way for the expansion of the microneedle or the microarray drug delivery systems market.

There has been a rise in the prevalence of chronic diseases such as diabetes, cancer, heart diseases, and stroke. Other lifestyle-related diseases such as chronic lung disease, chronic kidney disease, and Alzheimer's disease have also been on the rise over the past decade. In 2021, the Centers for Disease Control and Prevention listed that in the United States, six in ten adults have at least one chronic disease and four in ten adults have two or more. The increasing prevalence of such chronic diseases has also augmented the innovations in the microneedle drug delivery system. Thus, the microneedle drug delivery systems market is predicted to expand during the forecast period.

Microneedle Drug Delivery Systems Market Trends

The Dissolvable Microneedle Drug Delivery System Segment is Expected to Hold a Major Market Share

The dissolvable microneedle drug delivery systems are made mainly from dissolvable or biodegradable polymers. The dissolvable microneedles are a great option for the delivery of low molecular weight peptides, enzymes, drugs, vaccines, and biotherapeutics. The increased interest in the research of dissolvable microneedles is expected to boost the growth of the market.

For instance, in May 2021, HTL Biotechnology and Terasaki Institute of Biomedical Innovation announced an MOU that would help researchers in the microneedle and bioprinting technologies for application in dermatology and drug delivery. In October 2020, a team from the Terasaki Institute of Biomedical Innovation developed a novel biodegradable microneedle patch for gene therapy applications. The rise in recognition of dissolvable microneedle drug delivery systems by the government and healthcare research organizations is predicted to help the development of the segment in the market.

In September 2021, researchers from the National Science Foundation of China and Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences, fabricated a biodegradable microneedle patch for delivering DNA-based SARS-CoV-2 vaccine nanoparticles. The microneedle patches have a significant advantage over conventional vaccines in that they can be stored at room temperature for at least 30 days. This could improve the global accessibility of the COVID-19 vaccine.

The resilient, non-invasive, and efficient nature of the dissolvable microneedle drug delivery system is anticipated to aid in the advancement of the market during the forecast period.

North America is Expected to Hold a Significant Share in the Market

The rise in the adoption of highly advanced techniques and systems in the fabrication of microneedles and the technological advancements made in microneedle drug delivery are expected to boost the growth of the market in the North American region. The high awareness among the population of the availability of novel microneedle drug delivery systems in the market contributes to the high market growth in the region.

Also, the increasing prevalence of chronic diseases among people in the United States is expected to drive the demand for microneedle drug delivery systems in this region. According to the National Diabetes Statistics Report, in 2020, around 37.3 million people in the United States were found to have diabetes; around 96 million adults were found to have pre-diabetes. The National Kidney Foundation in 2020 has estimated that about 36 million adults in the United States have chronic kidney diseases. A report by the Centers for Disease Prevention and Control in 2020 showed that around 15.7 million Americans are affected by chronic lower respiratory disease. The massive incidence of chronic diseases among the population in the United States is expected to advance the expansion of the microneedle drug delivery systems market in the North American region.

Thus, the increasing awareness about the importance of microneedle drug delivery systems and increasing investments in the healthcare department are expected to propel the growth of the market in this region.

Microneedle Drug Delivery Systems Market Competitor Analysis

The microneedle drug delivery systems market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies currently dominating the market are 3M Company, Becton, Dickinson and Company, Raphas Co. Ltd, Nanopass Technologies, Corium Inc., Nitto Denko Corporation, Zealand Pharma AS, nanoBioSciences LLC, Micropoint Technologies, LTS Lohmann Therapie-Systeme AG, and others.

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Diseases and Lifestyle-related Disorders
4.2.2 Increasing Research on Painless Drug Delivery and Technological Advancement
4.2.3 Increasing Demand for a Safer Substitute to Conventional Hypodermic Injections
4.3 Market Restraints
4.3.1 Limited Number of Approved Products and Complications/Risks Associated with Microneedles
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 Product Type
5.1.1 Solid
5.1.2 Hollow
5.1.3 Coated
5.1.4 Dissolvable
5.2 Application
5.2.1 Drug Delivery
5.2.2 Vaccine Delivery
5.2.3 Dermatology
5.2.4 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3M Company
6.1.2 Becton, Dickinson and Company
6.1.3 Raphas Co. Ltd
6.1.4 Nanopass Technologies
6.1.5 Corium Inc.
6.1.6 Nitto Denko Corporation
6.1.7 Zealand Pharma AS
6.1.8 nanoBioSciences LLC
6.1.9 Micropoint Technologies
6.1.10 LTS Lohmann Therapie-Systeme AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $4750.00
  • $5250.00
  • $6500.00
  • $8750.00
  • ADD TO BASKET
  • BUY NOW